- Home
- TRUG vs CARM Comparison
TRUG vs CARM Comparison
Compare TRUG & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- CARM
- Stock Information
- Founded
- TRUG 1983
- CARM 2016
- Country
- TRUG United States
- CARM United States
- Employees
- TRUG N/A
- CARM N/A
- Industry
- TRUG
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- CARM Health Care
- Exchange
- TRUG NYSE
- CARM Nasdaq
- Market Cap
- TRUG 15.6M
- CARM 17.4M
- IPO Year
- TRUG N/A
- CARM N/A
- Fundamental
- Price
- TRUG $0.57
- CARM $0.44
- Analyst Decision
- TRUG Strong Buy
- CARM Hold
- Analyst Count
- TRUG 1
- CARM 5
- Target Price
- TRUG $2.00
- CARM $4.57
- AVG Volume (30 Days)
- TRUG 5.3M
- CARM 277.1K
- Earning Date
- TRUG 02-12-2025
- CARM 11-07-2024
- Dividend Yield
- TRUG N/A
- CARM N/A
- EPS Growth
- TRUG N/A
- CARM N/A
- EPS
- TRUG N/A
- CARM N/A
- Revenue
- TRUG $21,917,131.00
- CARM $20,268,000.00
- Revenue This Year
- TRUG N/A
- CARM $46.34
- Revenue Next Year
- TRUG N/A
- CARM N/A
- P/E Ratio
- TRUG N/A
- CARM N/A
- Revenue Growth
- TRUG 7.68
- CARM 41.13
- 52 Week Low
- TRUG $0.35
- CARM $0.38
- 52 Week High
- TRUG $9.36
- CARM $2.77
- Technical
- Relative Strength Index (RSI)
- TRUG 48.94
- CARM 37.99
- Support Level
- TRUG $0.54
- CARM $0.42
- Resistance Level
- TRUG $0.64
- CARM $0.48
- Average True Range (ATR)
- TRUG 0.12
- CARM 0.06
- MACD
- TRUG -0.01
- CARM 0.01
- Stochastic Oscillator
- TRUG 11.12
- CARM 18.67
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.